trimetazidine has been researched along with Angor Pectoris in 114 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (5.26) | 18.7374 |
1990's | 22 (19.30) | 18.2507 |
2000's | 57 (50.00) | 29.6817 |
2010's | 20 (17.54) | 24.3611 |
2020's | 9 (7.89) | 2.80 |
Authors | Studies |
---|---|
Joshi, SR; Nair, T | 1 |
Li, N; Liu, J; Qiu, L; Shen, L; Shu, H; Zhou, N | 1 |
El-Khodary, NM; El-Tayaar, AA; El-Touny, EM; Ghoneim, AI | 1 |
Cesar, LAM; Dourado, LOC; Gowdak, LHW; Grobe, SF; Moreno, CPD | 1 |
Arumugham, SS; Ashton, M; Berk, M; Colomer, L; Das, B; Dean, OM; Debnath, M; Giménez-Palomo, A; Goyal, N; Kesavan, M; Khanra, S; Kim, JH; McCallum, M; Pacchiarotti, I; Panizzutti, B; Park, CHJ; Reddy, P; Reddy, YCJ; Turner, A; Umesh, S; Venkatasubramanian, G; Vieta, E; Walder, K; Yatham, LN | 1 |
Chang, J; Choi, HY; Hong, SP; Jin, ES; Kong, MG; Kwon, SS; Park, GM; Park, RW; Park, S | 1 |
Thadani, U | 2 |
Al-Amran, F; Al-Aubaid, H; Fatima, G; Hadi, NR; Shaker, SR | 1 |
Robson, A | 1 |
Ciapponi, A; Harrison, J; Pizarro, R | 2 |
Kaski, JC; Tarkin, JM | 1 |
Caetano, PA; Heleno, B; Pinto, D; Rodrigues, DS; Santos, I; Silva, A | 1 |
Challeton, JP; Danchin, N; Ferrari, R; Ford, I; Fox, K; Marzilli, M; Tendera, M; Widimský, P | 1 |
Jones, DA; Timmis, A; Wragg, A | 1 |
Gao, F; Liu, Y; Ma, H; Ma, Q; Shen, H; Shi, D; Wang, Z; Xu, X; Yu, M; Zhang, J; Zhang, W; Zhao, Y; Zhou, Y; Zhou, Z | 1 |
Fillmore, N; Ilkayeva, OR; Jaswal, JS; Keung, W; Koves, TR; Lopaschuk, DG; Lopaschuk, GD; Mori, J; Muoio, DM; Ussher, JR; Wagg, CS; Zhang, L | 1 |
Fang, D; Fang, Q; Li, K; Peng, S; Wan, J; Zhao, M | 1 |
Fi, Z; Kovács, G; Szentes, V | 1 |
Ma, XJ; Shi, DZ; Zhang, Y | 1 |
Colombo, A; Fragasso, G; Fumero, A; Giannini, F; Godino, C; Maranta, F; Margonato, A; Oppizzi, M; Slavich, M | 1 |
Kerins, DM; McCarthy, CP; Mullins, KV | 1 |
Glezer, M | 1 |
Glezer M, G; On Behalf Of The Choice-Study Participants, OB | 1 |
Białoszyński, T; Grabczewska, Z; Grześk, G; Kochman, W; Koziński, M; Kubica, J; Sukiennik, A; Swiatkiewicz, I; Szymański, P | 1 |
Arora, R; Jawad, E | 1 |
Banach, M; Goch, A; Mikhailidis, DP; Rosano, GM; Rysz, J | 1 |
Kulikov, KG; Shal'nova, SA; Shkol'nik, EL; Vasiuk, IuA | 2 |
César, LA; Gowdak, LH; Mansur, AP | 1 |
Barone, L; Crea, F; Di Monaco, A; Lamendola, P; Lanza, GA; Pisanello, C | 1 |
Kudriakov, ON; Kulikov, KG; Shkol'nik, EL; Vasiuk, YA | 1 |
Antony, R; Dargie, HJ | 1 |
Chen, YD; Du, ZM; Jiang, H; Tian, F; Wei, M; Zhao, LK | 1 |
Chen, T; Guo, J; Hu, B; Li, W; Xu, T | 1 |
Simonenko, VB; Stepaniants, OS; Teslia, AN | 1 |
Bochkareva, EV; Butina, EK; Dmitrieva, NA; Kokurina, EV | 1 |
Maisch, B; Rupp, H; Zarain-Herzberg, A | 1 |
Fitilev, SB; Ivanova, EV; Lepakhin, VK; Levin, AM; Syrkin, AL; Titarova, IuIu | 1 |
Koziolova, NA | 1 |
Klein, WW; Marzilli, M | 1 |
Manchanda, SC | 1 |
Marzilli, M; Stanley, WC | 1 |
Artiukhina, EG; Chuntyzheva, MM; Kanorskiĭ, SG; Syrkin, AL | 1 |
Altinbas, A; Dogan, A; Ergene, O; Gedikli, O; Ozaydin, M | 1 |
Makolkin, VI; Osadchiĭ, KK | 1 |
Bada, V; Kölbel, F | 1 |
Almazov, VV; Kazarin, VV; Nifontov, EM; Rudomanov, OG; Shlyakhto, EV; Vakhrameyeva, IV; Vakhrameyeva, NV; Zakharov, DV | 1 |
Broustet, JP; Sellier, P | 1 |
Frenneaux, M; Horowitz, J; Lee, L | 1 |
Szwed, H | 2 |
Elikowski, W; Grzelak-Szafranska, H; Orszulak, W; Ruzyllo, W; Sadowski, Z; Szwed, H; Szymczak, K; Winter, M | 1 |
Lupanov, VP; Matveeva, MA; Mironova, IIu; Naumov, VG; Orlova, EM; Samoĭlenko, LE | 1 |
Adalet, K; Bilge, AK; Büyüköztürk, K; Koylan, N; Mercanoglu, F | 1 |
Bakhmatova, IuA; Gapon, LI; Kalinina, VA; Kuznetsov, VA; Petelina, TI; Todosiĭchuk, VV; Zhevagina, IA | 1 |
Gupta, R; Narain, VS; Sawhney, JP | 1 |
McCullough, PA | 1 |
Inglis, S; Stewart, S | 1 |
Meluzín, J | 1 |
Kölbel, F | 1 |
Chaloupka, V | 1 |
Danchin, N | 1 |
Amabile, N; Bonello, L; Com, O; Levy, S; Paganelli, F; Pierre, SV; Sbragia, P | 1 |
Baiandin, NL; Gordeev, IG; Il'ina, EE; Kuznechevskiĭ, FV; Liusov, VA | 1 |
Armaganijan, D; Bicudo, L; Brasil, CK; Cesar, LA; Del Monaco, MI; Gimenez, V; Gomes, EP; Jallad, S; Mathias, W; Meneguin, S; Ramires, JF | 1 |
Deev, AD; Glezer, MG; Oganov, RG | 1 |
Leitão, C; Polanczyk, CA; Ribeiro, JP; Ribeiro, LW; Stein, R | 1 |
Chaitman, BR; Sano, J | 1 |
Lévy, S | 2 |
Detry, JM; Leclercq, PJ | 1 |
Ribeiro, C | 1 |
Detry, JM | 1 |
Chierchia, SL; Fragasso, G | 1 |
Cokkinos, D; Dargie, H; Detry, JM; Mathes, P; Pennaforte, S; Sellier, P | 1 |
Coker, S; Détry, JM; Harpey, C; Maccario, J; Sellier, P | 1 |
Akimova, OS; Tereshchenko, SN; Tertychnaia, GF | 1 |
Krishnaswami, S; Manchanda, SC | 1 |
Jackson, G | 3 |
Allal, J; Harpey, C; Ourbak, P; Pornin, M; Sellier, P | 1 |
McClellan, KJ; Plosker, GL | 1 |
Akhmetov, KZh; Goncharov, LF; Goncharova, ZF; Kelimberdieva, ES; Komissarova, IA; Teĭblium, MM; Zaslavskaia, RM | 1 |
Kalinina, EV; Kelimberdieva, ES; Komissarova, IA; Novichkova, MD; Zaslavskaia, RM | 1 |
Kantor, PF; Kozak, R; Lopaschuk, GD; Lucien, A | 1 |
Domzal-Bochenska, M; Elikowski, W; Gajos, G; Kaluza, G; Kulon, I; Kuźniak, M; Pachocki, R; Paradowski, A; Szwed, H; Szydlowski, Z; Szymczak, K; Wator-Brzezińska, A | 1 |
Dzhanashiia, PKh; Glazunov, AV; Sorokoletov, SM; Urzhumova, TV; Zhiliaev, EV | 1 |
Baj, Z; Kowalski, J; Olejniczak, J; Paśnik, J; Pawlicki, L | 1 |
Kolycheva, SV; Lankin, VZ; Tikhaze, AK; Zharova, EA | 1 |
Hradec, J; Préda, I; Szwed, H | 1 |
Pogatsa, G | 1 |
Chernov, MIu; Chernov, SA; Davydova, TV; Korneev, NV; Kutepov, IuS; Makarenkova, LA; Sharonova, SP; Spicheva, IA; Tiurin, VP; Virs, EA | 1 |
Cross, HR | 1 |
Elikowski, W; Koronkiewicz, A; Mamcarz, A; Orszulak, W; Sadowski, Z; Skibińska, E; Swiatek, J; Szwed, H; Szymczak, K; Winter, M | 1 |
Auteri, A; Blardi, P; de Lalla, A; Di Perri, T; Volpi, L | 1 |
Stanley, WC | 1 |
Durr, F; Faucon, G; Harpey, C; Timour, Q | 1 |
Audouin, P; Corona, P; Harpey, C; Ourbak, P; Sellier, P | 1 |
Sellier, P | 2 |
Brochier, M; Demange, J; Ducloux, G; Monpère, C; Warin, JF | 1 |
Berckmans, T; Detry, JM; Fesler, R; Leclercq, P | 1 |
Dalla-Volta, S; Della-Valentina, P; Desideri, A; Maraglino, G; Viena, P | 1 |
Ayudhya, RK; Jintapakorn, W; Suntiparpluacha, C; Yipintsoi, S; Yipintsoi, T | 1 |
Barat, JL; Bonnet, J; Boussens, B; Bricaud, H; Brottier, L; Combe, C | 1 |
Audouin, P; Duong, TC; Ourbak, P; Payen, B; Sellier, P | 1 |
Passeron, J | 1 |
Gallet, M | 2 |
Audouin, P; Corona, P; Duong, TC; Ourbak, P; Payen, B; Sellier, P | 1 |
31 review(s) available for trimetazidine and Angor Pectoris
Article | Year |
---|---|
Metabolic regulation to treat bipolar depression: mechanisms and targeting by trimetazidine.
Topics: Angina Pectoris; Antioxidants; Bipolar Disorder; Humans; Trimetazidine; Vasodilator Agents | 2023 |
WITHDRAWN: Trimetazidine for stable angina.
Topics: Adult; Angina Pectoris; Humans; Randomized Controlled Trials as Topic; Trimetazidine; Vasodilator Agents | 2017 |
Novel drugs for treating angina.
Topics: Acetanilides; Angina Pectoris; Benzazepines; Enzyme Inhibitors; Heart Rate; Humans; Ivabradine; Nicorandil; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2013 |
The efficacy of trimetazidine on stable angina pectoris: a meta-analysis of randomized clinical trials.
Topics: Angina Pectoris; Humans; Randomized Controlled Trials as Topic; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2014 |
[Role of trimetazidine in the treatment of diabetic microangiopathy in ischaemic heart disease].
Topics: Angina Pectoris; Anti-Inflammatory Agents, Non-Steroidal; Coronary Artery Disease; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Heart; Humans; Myocardial Infarction; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents | 2015 |
Effect of Trimetazidine in Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis.
Topics: Angina Pectoris; Female; Humans; Male; Models, Biological; Myocardium; Natriuretic Peptide, Brain; Percutaneous Coronary Intervention; Stroke Volume; Trimetazidine; Troponin I; Ultrasonography | 2015 |
The role of trimetazidine in cardiovascular disease: beyond an anti-anginal agent.
Topics: Angina Pectoris; Animals; Humans; Trimetazidine; Vasodilator Agents | 2016 |
Chronic stable angina pectoris.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acetanilides; Angina Pectoris; Antihypertensive Agents; Benzazepines; Bosentan; Chronic Disease; Counterpulsation; Cyclic Nucleotide-Gated Cation Channels; Exercise Test; Heart Murmurs; Humans; Ivabradine; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Nicorandil; Oxygen Consumption; Perhexiline; Piperazines; Protein Kinase Inhibitors; Ranolazine; Sulfonamides; Trimetazidine; Vasodilator Agents | 2008 |
The role of trimetazidine after acute myocardial infarction.
Topics: Acute Coronary Syndrome; Angina Pectoris; Cardiovascular Agents; Energy Metabolism; Humans; Myocardial Infarction; Myocardium; Practice Guidelines as Topic; Treatment Outcome; Trimetazidine | 2008 |
The metabolic treatment of patients with coronary artery disease: effects on quality of life and effort angina.
Topics: Acetanilides; Angina Pectoris; Animals; Carnitine; Clinical Trials as Topic; Coronary Artery Disease; Dichloroacetic Acid; Humans; Piperazines; Quality of Life; Ranolazine; Ribose; Surveys and Questionnaires; Trimetazidine; Vasodilator Agents | 2009 |
[Mechanisms of myocardial cell protection from ischemia/reperfusion injury and potential clinical implications].
Topics: Acetanilides; Acute Coronary Syndrome; Angina Pectoris; Animals; Apoptosis; Cell Death; Collateral Circulation; Disease Models, Animal; Humans; Ischemic Preconditioning, Myocardial; Meta-Analysis as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Myocytes, Cardiac; Oxygen Consumption; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Trimetazidine; Vasodilator Agents | 2009 |
[Effect of therapy with trimetazidine modified release on quality of life of patients with stable effort angina survivors after acute myocardial infarction. Results of PRIMA study].
Topics: Angina Pectoris; Delayed-Action Preparations; Dose-Response Relationship, Drug; Humans; Myocardial Infarction; Quality of Life; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2010 |
Evaluation of trimetazidine in angina pectoris by echocardiography and radionuclide angiography: a meta-analysis of randomized, controlled trials.
Topics: Aged; Angina Pectoris; Drug Therapy, Combination; Echocardiography; Evidence-Based Medicine; Female; Humans; Male; Middle Aged; Predictive Value of Tests; Radionuclide Angiography; Randomized Controlled Trials as Topic; Stroke Volume; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2011 |
The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.
Topics: Acetanilides; Angina Pectoris; Animals; Calcium; Cardiovascular Agents; Clinical Trials as Topic; Enzyme Inhibitors; Epoxy Compounds; Fatty Acids; Gene Expression; Glucose; Heart Failure; Humans; Hypoglycemic Agents; Methylhydrazines; Myocytes, Cardiac; Oxidation-Reduction; Piperazines; Ranolazine; Rats; Rats, Wistar; Sarcoplasmic Reticulum; Trimetazidine; Up-Regulation; Vasodilator Agents | 2002 |
Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
Topics: Aged; Angina Pectoris; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Nitroglycerin; Severity of Illness Index; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2003 |
Metabolic therapy in the treatment of ischaemic heart disease: the pharmacology of trimetazidine.
Topics: Angina Pectoris; Carbohydrate Metabolism; Diabetes Complications; Diabetes Mellitus; Energy Metabolism; Fatty Acids; Humans; Myocardial Ischemia; Myocardium; Trimetazidine; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Metabolic manipulation in ischaemic heart disease, a novel approach to treatment.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Cardiovascular Agents; Drug Therapy, Combination; Enzyme Inhibitors; Epoxy Compounds; Glucose; Humans; Hypoglycemic Agents; Insulin; Myocardial Ischemia; Myocardium; Perhexiline; Piperazines; Potassium; Ranolazine; Trimetazidine | 2004 |
Clinical benefits of trimetazidine in patients with recurrent angina.
Topics: Angina Pectoris; Humans; Myocardial Revascularization; Randomized Controlled Trials as Topic; Recurrence; Trimetazidine; Vasodilator Agents | 2004 |
Chronic angina: new medical options for treatment.
Topics: Acetanilides; Angina Pectoris; Cardiovascular Agents; Chronic Disease; Enzyme Inhibitors; Humans; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 2005 |
Trimetazidine for stable angina.
Topics: Adult; Angina Pectoris; Humans; Randomized Controlled Trials as Topic; Trimetazidine; Vasodilator Agents | 2005 |
Metabolic therapeutics in angina pectoris: history revisited with perhexiline.
Topics: Acetanilides; Angina Pectoris; Calcium Channel Blockers; Cardiovascular Agents; Carnitine O-Palmitoyltransferase; Drug Monitoring; Epoxy Compounds; Fatty Acids; Half-Life; Humans; Metabolic Clearance Rate; Nurse's Role; Nursing Assessment; Patient Education as Topic; Patient Selection; Perhexiline; Piperazines; Randomized Controlled Trials as Topic; Ranolazine; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2006 |
Clinical benefits of a metabolic approach with trimetazidine in revascularized patients with angina.
Topics: Angina Pectoris; Electrocardiography; Humans; Myocardial Revascularization; Postoperative Period; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2006 |
Novel therapeutic approaches to treating chronic angina in the setting of chronic ischemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Chronic Disease; Enzyme Inhibitors; Humans; Ivabradine; Myocardial Ischemia; Nicorandil; Nitro Compounds; Piperazines; Ranolazine; rho-Associated Kinases; Sinoatrial Node; Trimetazidine; Vasodilator Agents | 2007 |
Clinical features of an anti-anginal drug in angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Male; Middle Aged; Nifedipine; Trimetazidine | 1993 |
Metabolic management of ischaemic heart disease.
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Energy Metabolism; Humans; Myocardium; Nitroglycerin; Piperazines; Ranolazine; Trimetazidine | 1993 |
Trimetazidine. A review of its use in stable angina pectoris and other coronary conditions.
Topics: Angina Pectoris; Animals; Coronary Disease; Humans; Trimetazidine; Vasodilator Agents | 1999 |
Anti-ischaemic efficacy and tolerability of trimetazidine administered to patients with angina pectoris: results of three studies.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Double-Blind Method; Drug Tolerance; Exercise Test; Exercise Tolerance; Humans; Metoprolol; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Trimetazidine; Vasodilator Agents | 2001 |
Metabolic energy metabolism in diabetes: therapeutic implications.
Topics: Angina Pectoris; Animals; Circadian Rhythm; Diabetic Angiopathies; Energy Metabolism; Glycolysis; Humans; Myocardial Reperfusion; Myocardium; Trimetazidine; Vasodilator Agents | 2001 |
Trimetazidine for stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Animals; Calcium Channel Blockers; Coronary Artery Bypass; Exercise Test; Humans; Nitroglycerin; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2001 |
Combination therapy in angina: a review of combined haemodynamic treatment and the role for combined haemodynamic and cardiac metabolic agents.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Nitrates; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2001 |
Partial fatty acid oxidation inhibitors for stable angina.
Topics: Acetanilides; Adenosine Triphosphate; Angina Pectoris; Chronic Disease; Energy Metabolism; Fatty Acids; Humans; Myocardium; Oxidation-Reduction; Oxygen Consumption; Piperazines; Ranolazine; Trimetazidine | 2002 |
52 trial(s) available for trimetazidine and Angor Pectoris
Article | Year |
---|---|
The Impact of Trimetazidine on Cardiac Fibrosis, Inflammation, and Function in Ischemic Cardiomyopathy Patients.
Topics: Angina Pectoris; Cardiomyopathies; Fibrosis; Humans; Inflammation; Myocardial Ischemia; Trimetazidine; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2023 |
Trimetazidine Improves the Outcome of EECP Therapy in Patients with Refractory Angina Pectoris.
Topics: Angina Pectoris; Chaperonin 60; Chemokine CCL2; Combined Modality Therapy; Counterpulsation; Double-Blind Method; F2-Isoprostanes; Female; Humans; Interleukin-1beta; Male; Middle Aged; Mitochondrial Proteins; Monocytes; Patient Satisfaction; Prospective Studies; Toll-Like Receptor 2; Trimetazidine; Vasodilator Agents | 2020 |
A randomized, double-blind, placebo-controlled trial to assess the efficAcy and safety of Trimetazidine in patients with angina pectoris having been treated by percutaneous coronary intervention (ATPCI study): Rationale, design, and baseline characteristi
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Placebos; Postoperative Complications; Recurrence; Trimetazidine; Vasodilator Agents; Young Adult | 2019 |
Effect of trimetazidine on recurrent angina pectoris and left ventricular structure in elderly multivessel coronary heart disease patients with diabetes mellitus after drug-eluting stent implantation: a single-centre, prospective, randomized, double-blind
Topics: Aged; Aged, 80 and over; Angina Pectoris; Coronary Disease; Diabetes Complications; Double-Blind Method; Drug-Eluting Stents; Female; Follow-Up Studies; Humans; Male; Secondary Prevention; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2014 |
[Evaluation of the myocardial protection of trimetazidine during percutaneous coronary intervention: a multi-center randomized and controlled clinical study].
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Female; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents | 2010 |
[The (PRIMA) Study. Comparison of clinical effect of trimetazidine MR in men and women].
Topics: Aged; Angina Pectoris; Cardiotonic Agents; Drug Monitoring; Exercise Test; Female; Heart Failure; Humans; Male; Middle Aged; Myocardial Infarction; Nitro Compounds; Russia; Severity of Illness Index; Sex Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2011 |
[Myocardial cytoprotectors, a reserve therapeutic modality for patients with stable angina of effort].
Topics: Aged; Angina Pectoris; Cytoprotection; Drug Therapy, Combination; Female; Humans; Male; Myocardium; Picolines; Trimetazidine; Ubiquinone | 2011 |
[Decrease in the sensitivity to the anti-ischemic effect of propranolol and prospects for correcting it in patients with stable angina pectoris].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Myocardial Ischemia; Placebos; Propranolol; Trimetazidine | 2002 |
[Trimetazidine in pectoris patients older than 65 years with stable angina].
Topics: Aged; Angina Pectoris; Female; Humans; Male; Quality of Life; Severity of Illness Index; Surveys and Questionnaires; Trimetazidine; Vasodilator Agents | 2002 |
[Efficacy of trimetazidine in stable angina pectoris refractory to traditional treatment].
Topics: Angina Pectoris; Female; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents | 2002 |
Efficacy and tolerability of trimetazidine in stable angina: a meta-analysis of randomized, double-blind, controlled trials.
Topics: Aged; Angina Pectoris; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Humans; Male; Middle Aged; Nitroglycerin; Severity of Illness Index; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2003 |
Treatment of stable angina with low dose diltiazem in combination with the metabolic agent trimetazidine.
Topics: Aged; Angina Pectoris; Apolipoproteins; Diltiazem; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Trimetazidine; Vasodilator Agents | 2003 |
[Antiischemic efficacy of trimetazidine in patients with intermittent claudication and effort angina].
Topics: Aged; Angina Pectoris; Arteriosclerosis; Arteriosclerosis Obliterans; Humans; Intermittent Claudication; Male; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2003 |
[Efficacy and tolerability of trimetazidine in the treatment of stable effort angina (TRIUMPH Study in Russia)].
Topics: Angina Pectoris; Female; Humans; Hypotension; Male; Middle Aged; Nausea; Patient Compliance; Quality of Life; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2003 |
Antianginal effects of trimetazidine and left ventricular function improvement in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Chronic Disease; Drug Therapy, Combination; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Nitrates; Treatment Outcome; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2002 |
Assessment of anti-ischemic and antianginal effect at trough plasma concentration and safety of trimetazidine MR 35 mg in patients with stable angina pectoris: a multicenter, double-blind, placebo-controlled study.
Topics: Administration, Oral; Adolescent; Adult; Aged; Angina Pectoris; Double-Blind Method; Europe; Exercise Test; Female; Humans; Israel; Latvia; Male; Middle Aged; Myocardial Ischemia; Russia; Severity of Illness Index; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2003 |
Efficacy of trimetazidine in patients with recurrent angina: a subgroup analysis of the TRIMPOL II study.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Male; Metoprolol; Middle Aged; Recurrence; Trimetazidine; Vasodilator Agents | 2004 |
Comparison of the effects of trimetazidine and diltiazem on exercise performance in patients with coronary heart disease. The Turkish trimetazidine study (TTS).
Topics: Adolescent; Adult; Aged; Angina Pectoris; Diltiazem; Double-Blind Method; Exercise Tolerance; Humans; Male; Middle Aged; Prospective Studies; Trimetazidine; Vasodilator Agents | 2004 |
[Anti-ischemic efficacy of combination of trimetazidine with enalapril in patients with stable effort angina and metabolic syndrome].
Topics: Adult; Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Electrocardiography, Ambulatory; Enalapril; Female; Follow-Up Studies; Humans; Male; Metabolic Syndrome; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2005 |
[Trimetazidine in the treatment of stable angina pectoris TRIADA-(trimetazidine in stable angina twice daily)].
Topics: Angina Pectoris; Humans; Trimetazidine; Vasodilator Agents | 2006 |
Protective effect of an acute oral loading dose of trimetazidine on myocardial injury following percutaneous coronary intervention.
Topics: Administration, Oral; Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Contrast Media; Coronary Angiography; Female; Heart Injuries; Humans; Male; Middle Aged; Premedication; Prospective Studies; Stents; Trimetazidine; Troponin I; Vasodilator Agents | 2007 |
Trimetazidine to reverse ischemia in patients with class I or II angina: a randomized, double-blind, placebo-controlled dobutamine-atropine stress echocardiography study.
Topics: Aged; Angina Pectoris; Atropine; Dobutamine; Double-Blind Method; Echocardiography, Stress; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2007 |
[Program for detection of patients with ineffective therapy with beta-adrenoblockers and comparative assessment of efficacy of addition of trimetazidine MB or isosorbide dinitrate in stable angina. Results of a Russian Study Parrallel].
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Aged, 80 and over; Angina Pectoris; Data Interpretation, Statistical; Drug Therapy, Combination; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Quality of Life; Risk Factors; Russia; Smoking; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2007 |
Trimetazidine added to combined hemodynamic antianginal therapy in patients with type 2 diabetes: a randomized crossover trial.
Topics: Angina Pectoris; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Administration Schedule; Electrocardiography, Ambulatory; Exercise Test; Female; Humans; Male; Middle Aged; Trimetazidine | 2007 |
[Value of the combination of trimetazidine (Vastarel 20 mg) with diltiazem (Tildiem 60 mg) in stable effort angina. A double-blind versus placebo multicenter study].
Topics: Angina Pectoris; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Humans; Male; Middle Aged; Physical Exertion; Trimetazidine | 1995 |
Combination therapy of trimetazidine with diltiazem in patients with coronary artery disease. Group of South of France Investigators.
Topics: Administration, Oral; Angina Pectoris; Coronary Disease; Diltiazem; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Exercise Test; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Trimetazidine | 1995 |
Trimetazidine European Multicenter Study versus propranolol in stable angina pectoris: contribution of Holter electrocardiographic ambulatory monitoring.
Topics: Angina Pectoris; Circadian Rhythm; Double-Blind Method; Electrocardiography, Ambulatory; Europe; Humans; Male; Propranolol; Treatment Outcome; Trimetazidine | 1995 |
Trimetazidine: a new concept in the treatment of angina. Comparison with propranolol in patients with stable angina. Trimetazidine European Multicenter Study Group.
Topics: Angina Pectoris; Blood Pressure; Double-Blind Method; Electrocardiography; Exercise Tolerance; Heart Rate; Humans; Male; Middle Aged; Propranolol; Reproducibility of Results; Trimetazidine | 1994 |
Permutation distribution estimation applied to the comparison of the profile of the activity of two antianginal drugs.
Topics: Angina Pectoris; Data Interpretation, Statistical; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Tolerance; Humans; Male; Middle Aged; Propranolol; Trimetazidine; Vasodilator Agents | 1996 |
Combination treatment with trimetazidine and diltiazem in stable angina pectoris.
Topics: Angina Pectoris; Calcium Channel Blockers; Diltiazem; Double-Blind Method; Drug Therapy, Combination; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents | 1997 |
Lack of effects of trimetazidine on systemic hemodynamics in patients with coronary artery disease: a placebo-controlled study.
Topics: Angina Pectoris; Aorta; Blood Pressure; Cardiac Output; Coronary Disease; Double-Blind Method; Exercise Tolerance; Female; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Male; Middle Aged; Placebos; Pulmonary Wedge Pressure; Trimetazidine; Vascular Resistance; Ventricular Function, Left; Ventricular Pressure | 1994 |
[Comparative efficacy of combined therapy with preductal and amino acid composition in elderly patients with coronary heart disease and class II-III angina].
Topics: Aged; Aged, 80 and over; Angina Pectoris; Cysteine; Drug Therapy, Combination; Echocardiography; Electrocardiography, Ambulatory; Female; Glutamic Acid; Glycine; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Treatment Outcome; Trimetazidine; Vasodilator Agents | 1999 |
[Effects of metabolic therapy on intracellular level of antioxidant system in elderly patients with ischemic heart disease].
Topics: Aged; Amino Acids; Angina Pectoris; Drug Therapy, Combination; Erythrocytes; Female; Glutathione; Humans; Intracellular Fluid; Lipid Peroxidation; Male; Oxidation-Reduction; Oxidoreductases; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2000 |
[Efficacy and tolerance of trimetazidine, a metabolic antianginal, in combination with a hemodynamic antianginal in stable exertion angina. TRIMPOL I, a multicenter study].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Calcium; Drug Evaluation; Drug Therapy, Combination; Exercise Test; Female; Humans; Male; Middle Aged; Nitrates; Trimetazidine; Vasodilator Agents | 2000 |
[Clinical aspects of trimetazidine (preductal) administration as an antianginal drug].
Topics: Administration, Oral; Aged; Aged, 80 and over; Angina Pectoris; Cross-Over Studies; Drug Therapy, Combination; Electrocardiography; Exercise Test; Female; Humans; Isosorbide Dinitrate; Male; Middle Aged; Nifedipine; Prognosis; Propranolol; Trimetazidine; Vasodilator Agents; Verapamil | 2000 |
[Effect of trimetazidine on biological activity of neutrophils in patients with transient myocardial ischemia induced by exercise testing].
Topics: Adult; Angina Pectoris; Cell Aggregation; Exercise Test; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Neutrophils; Trimetazidine | 2000 |
Trimetazidine as indirect antioxidant.
Topics: Angina Pectoris; Antioxidants; Coronary Disease; Erythrocytes; Glutathione Peroxidase; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Superoxide Dismutase; Trimetazidine; Vasodilator Agents | 2000 |
[Combined therapy with nitrosorbide and preductal in patients with ischemic heart disease].
Topics: Angina Pectoris; Drug Therapy, Combination; Humans; Isosorbide Dinitrate; Male; Middle Aged; Trimetazidine | 2000 |
Combination treatment in stable effort angina using trimetazidine and metoprolol: results of a randomized, double-blind, multicentre study (TRIMPOL II). TRIMetazidine in POLand.
Topics: Administration, Oral; Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Europe; Exercise Test; Female; Humans; Male; Metoprolol; Middle Aged; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2001 |
Increase of adenosine plasma levels after oral trimetazidine: a pharmacological preconditioning?
Topics: Adenosine; Aged; Analysis of Variance; Angina Pectoris; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Time Factors; Trimetazidine; Vasodilator Agents | 2002 |
Acute effects of trimetazidine on ergometric parameters in effort angina.
Topics: Analysis of Variance; Angina Pectoris; Blood Pressure; Double-Blind Method; Electrocardiography; Exercise Test; Heart Rate; Humans; Male; Middle Aged; Trimetazidine | 1990 |
Chronic effects of trimetazidine on ergometric parameters in effort angina.
Topics: Angina Pectoris; Double-Blind Method; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Time Factors; Trimetazidine | 1990 |
Combination of trimetazidine with nifedipine in effort angina.
Topics: Angina Pectoris; Double-Blind Method; Drug Therapy, Combination; Exercise Test; Humans; Male; Middle Aged; Nifedipine; Trimetazidine | 1990 |
A new semiautomated algorithm to quantify Holter-detected myocardial ischemia: preliminary experience in the Trimetazidine European Multicenter trial (TEMS).
Topics: Algorithms; Angina Pectoris; Automation; Circadian Rhythm; Double-Blind Method; Electrocardiography, Ambulatory; Exercise Test; Humans; Trimetazidine | 1990 |
Comparison of trimetazidine with nifedipine in effort angina: a double-blind, crossover study.
Topics: Adult; Aged; Angina Pectoris; Double-Blind Method; Exercise; Humans; Male; Middle Aged; Nifedipine; Trimetazidine | 1990 |
Trimetazidine and stable angina a double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Humans; Male; Medical Records; Middle Aged; Piperazines; Trimetazidine | 1990 |
Therapeutic value of a cardioprotective agent in patients with severe ischaemic cardiomyopathy.
Topics: Angina Pectoris; Cardiomyopathies; Coronary Disease; Double-Blind Method; Drug Evaluation; Female; Hemodynamics; Humans; Male; Middle Aged; Piperazines; Trimetazidine | 1990 |
[Ergometric effects of a single administration of trimetazidine].
Topics: Administration, Oral; Angina Pectoris; Double-Blind Method; Exercise Test; Humans; Male; Middle Aged; Nitroglycerin; Piperazines; Trimetazidine | 1986 |
[Effectiveness of trimetazidine in stable effort angina due to chronic coronary insufficiency. A double-blind versus placebo study].
Topics: Angina Pectoris; Chronic Disease; Coronary Disease; Double-Blind Method; Exercise Test; Humans; Male; Piperazines; Trimetazidine | 1986 |
[Clinical effectiveness of trimetazidine in stable effort angina. A double-blind versus placebo controlled study].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Humans; Male; Middle Aged; Piperazines; Random Allocation; Trimetazidine | 1986 |
[The effects of trimetazidine on ergometric parameters in exercise-induced angina. Controlled multicenter double blind versus placebo study].
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Electrocardiography; Exercise Test; Hemodynamics; Humans; Male; Middle Aged; Physical Exertion; Piperazines; Trimetazidine | 1986 |
Acute effects of trimetazidine evaluated by exercise testing.
Topics: Angina Pectoris; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Piperazines; Trimetazidine | 1987 |
32 other study(ies) available for trimetazidine and Angor Pectoris
Article | Year |
---|---|
Do we need to change the Patient Indications for Trimetazidine after ATPCI?
Topics: Angina Pectoris; Humans; Percutaneous Coronary Intervention; Research Design; Trimetazidine; Vasodilator Agents | 2021 |
Clinical Implications of Nicorandil Combined with Trimetazidine in Patients with Coronary Heart Disease: A Real-World Observational Study.
Topics: Adult; Angina Pectoris; Coronary Disease; Humans; Nicorandil; Retrospective Studies; Trimetazidine | 2022 |
Concomitant Use of Ranolazine and Trimetazidine in Patients with Refractory Angina: An Initial Experience.
Topics: Angina Pectoris; Angina, Stable; Cardiovascular Agents; Humans; Ranolazine; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2022 |
Impact of Trimetazidine on the Incident Heart Failure After Coronary Artery Revascularization.
Topics: Angina Pectoris; Coronary Vessels; Heart Failure; Humans; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2023 |
Trimetazidine for stable and unstable ischemic heart diseases and for heart failure: Is its routine use justified from available data?
Topics: Angina Pectoris; Heart Failure; Humans; Myocardial Ischemia; Trimetazidine | 2020 |
Trimetazidine not beneficial after PCI.
Topics: Angina Pectoris; Double-Blind Method; Humans; Percutaneous Coronary Intervention; Trimetazidine; Vasodilator Agents | 2020 |
Trimetazidine: is there a role beyond angina?
Topics: Angina Pectoris; Humans; Trimetazidine; Vasodilator Agents | 2018 |
Effect of European Medicines Agency's restrictions on trimetazidine utilization in Portugal.
Topics: Angina Pectoris; Drug Labeling; Drug Prescriptions; Drug Utilization; Drug Utilization Review; European Union; Humans; National Health Programs; Parkinsonian Disorders; Portugal; Retrospective Studies; Trimetazidine; Vasodilator Agents | 2018 |
Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice.
Topics: Acetyl-CoA C-Acyltransferase; Angina Pectoris; Animals; Cells, Cultured; Diet, High-Fat; Fatty Acids; Glucose Tolerance Test; Insulin; Insulin Resistance; Lipid Metabolism; Mice; Mice, Inbred C57BL; Muscle Fibers, Skeletal; Myocytes, Cardiac; Obesity; Oxidation-Reduction; Rats; Trimetazidine; Vasodilator Agents | 2014 |
Long-Term Preservation of Left Ventricular Systolic Function in Patients With Refractory Angina Pectoris and Inducible Myocardial Ischemia on Optimal Medical Therapy.
Topics: Aged; Angina Pectoris; Benzazepines; Cardiovascular Agents; Echocardiography; Exercise Test; Female; Follow-Up Studies; Humans; Ivabradine; Male; Myocardial Ischemia; Ranolazine; Retrospective Studies; Sodium Channel Blockers; Stroke Volume; Systole; Time Factors; Tomography, Emission-Computed, Single-Photon; Trimetazidine; Vasodilator Agents; Ventricular Function, Left | 2016 |
Real-world Evidence for the Antianginal Efficacy of Trimetazidine from the Russian Observational CHOICE-2 Study.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nitrates; Prospective Studies; Russia; Trimetazidine; Vasodilator Agents | 2017 |
[Treatment of Patients With Stable Ischemic Heart Disease in Real Clinical Practice in Russia. The CHOICE-2 Program].
Topics: Angina Pectoris; Coronary Artery Disease; Humans; Myocardial Ischemia; Russia; Trimetazidine | 2016 |
The effect of trimetazidine added to maximal anti-ischemic therapy in patients with advanced coronary artery disease.
Topics: Aged; Angina Pectoris; Coronary Angiography; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Exercise Test; Exercise Tolerance; Female; Follow-Up Studies; Humans; Male; Middle Aged; Probability; Prospective Studies; Risk Assessment; Severity of Illness Index; Statistics, Nonparametric; Time Factors; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2008 |
[The PRIMA study: trimetazidin in the treatment of patients with stable angina pectoris after myocardial infarction. Epidemiological and clinical phases].
Topics: Adult; Aged; Aged, 80 and over; Angina Pectoris; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Russia; Survival Rate; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2008 |
Allopurinol for chronic stable angina: old drug, new tricks?
Topics: Allopurinol; Angina Pectoris; Cardiovascular Agents; Chronic Disease; Enzyme Inhibitors; Humans; Trimetazidine; Vasodilator Agents | 2010 |
Effect of trimetazidine on exercise performance in patients with coronary artery ectasia.
Topics: Aged; Angina Pectoris; Coronary Artery Disease; Coronary Circulation; Dilatation, Pathologic; Electrocardiography; Exercise Test; Humans; Male; Middle Aged; Trimetazidine; Vasodilator Agents | 2003 |
Trimetazidine in geriatric patients with stable angina pectoris: the tiger study.
Topics: Aged; Aged, 80 and over; Angina Pectoris; Drug Evaluation; Exercise Therapy; Female; Humans; Male; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2003 |
[Assessment of antianginal and antiischemic effect of trimetazidine and its effects on myocardial perfusion in patients with ischemic heart disease and stable angina.].
Topics: Angina Pectoris; Angina, Stable; Coronary Artery Disease; Humans; Myocardial Ischemia; Trimetazidine; Vasodilator Agents | 2004 |
Treatment of stable angina pectoris with trimetazidine modified release in Indian primary-care practice.
Topics: Aged; Angina Pectoris; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lipids; Male; Middle Aged; Primary Health Care; Prospective Studies; Trimetazidine; Vasodilator Agents | 2005 |
Modified-release formulation of trimetazidine for exceptional control of angina pectoris: fact or fiction.
Topics: Angina Pectoris; Chemistry, Pharmaceutical; Delayed-Action Preparations; Drug Administration Schedule; Drug Therapy, Combination; Humans; Trimetazidine; Vasodilator Agents | 2005 |
[Treatment of stable angina pectoris with trimetazidine].
Topics: Angina Pectoris; Humans; Trimetazidine; Vasodilator Agents | 2006 |
[Modulation of myocardial metabolism with trimetazidine].
Topics: Angina Pectoris; Energy Metabolism; Humans; Myocardium; Trimetazidine; Vasodilator Agents | 2006 |
[Derangements of contractility of left ventricular myocardium in patients subjected to coronary bypass surgery. Methods of their correction].
Topics: Adult; Aged; Angina Pectoris; Cardiotonic Agents; Coronary Artery Bypass; Female; Humans; Male; Methylhydrazines; Middle Aged; Myocardial Contraction; Postoperative Complications; Trimetazidine; Ventricular Dysfunction, Left | 2007 |
[Therapeutic application of myocardial cytoprotection].
Topics: Acetanilides; Adrenergic beta-Antagonists; Angina Pectoris; Calcium Channel Blockers; Carnitine; Humans; Myocardial Ischemia; Niacinamide; Nicorandil; Piperazines; Ranolazine; Trimetazidine; Vasodilator Agents | 1994 |
[The use of trimetazidine in the combined therapy of postinfarct stenocardia].
Topics: Acute Disease; Aged; Angina Pectoris; Drug Evaluation; Humans; Male; Myocardial Infarction; Trimetazidine; Vasodilator Agents | 1997 |
Angina, myocardial hibernation and trimetazidine.
Topics: Angina Pectoris; Humans; Myocardial Ischemia; Myocardial Stunning; Trimetazidine; Vasodilator Agents | 1997 |
The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase.
Topics: Angina Pectoris; Animals; Carboxy-Lyases; Dose-Response Relationship, Drug; Energy Metabolism; Esters; Fatty Acids; Glucose; Glycolysis; Male; Malonyl Coenzyme A; Mitochondria; Mitochondrial Trifunctional Protein; Multienzyme Complexes; Myocardial Ischemia; Myocardium; Pyruvate Dehydrogenase Complex; Rats; Rats, Sprague-Dawley; Trimetazidine; Vasodilator Agents | 2000 |
Haemodynamic and metabolic agents in the treatment of stable angina: publication review.
Topics: Angina Pectoris; Energy Metabolism; Hemodynamics; Humans; Myocardium; Trimetazidine; Vasodilator Agents | 2001 |
Comments on EMIP-FR study's editorial.
Topics: Angina Pectoris; Humans; Myocardial Infarction; Treatment Outcome; Trimetazidine; Vasodilator Agents | 2001 |
Trimetazidine: a second look. Just a placebo.
Topics: Angina Pectoris; Drug Therapy, Combination; France; Humans; Placebos; Propranolol; Randomized Controlled Trials as Topic; Tinnitus; Treatment Outcome; Trimetazidine; Vasodilator Agents; Vertigo | 2000 |
Is the antianginal action of trimetazidine independent of hemodynamic changes?
Topics: Angina Pectoris; Animals; Dogs; Dose-Response Relationship, Drug; Hemodynamics; Trimetazidine | 1991 |
[Current concepts in cellular ischemia: role of trimetazidine].
Topics: Angina Pectoris; Double-Blind Method; Drug Evaluation; Electrocardiography; Hemodynamics; Humans; Physical Exertion; Piperazines; Random Allocation; Trimetazidine | 1986 |